MedPath

Observational Trial of Hepatitis C Virus Infected Patients on Calcineurin Inhibitors

Completed
Conditions
Hepatitis C Virus
Registration Number
NCT00819026
Lead Sponsor
University of Wisconsin, Madison
Brief Summary

Hepatitis C Virus is constantly evolving genetically, particularly in response to the immune system. This is an observational study to examine if immunosuppressants particularly calcineurin inhibitors taken by transplant patients in order to avoid organ rejection causes predictable changes in the genetics of this virus that might be important in order to treat it effectively.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
15
Inclusion Criteria
  • HCV infected on immunosuppression
Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Wisconsin

🇺🇸

Madison, Wisconsin, United States

© Copyright 2025. All Rights Reserved by MedPath